Summary
SHARES in SkyePharma tumbled 9pc as the drugs delivery firm revealed that it must carry out more tests on its asthma drug Flutiform.
The powerful US Food and Drug Administration has insisted Skye gathers more data on the effects of different doses.See the full content of this document
Extract
Skyepharma Hit by Asthma Setback
This pushes the exp...
See the full content of this document